FHA
UTHR icon

Flagship Harbor Advisors’s United Therapeutics UTHR Stock Holding History

Flagship Harbor Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-108
Closed -$52.6K – 2123
2025
Q4 		$52.6K Sell
108
-871
-89% -$406K ﹤0.01% 1049
2025
Q3 		$410K Sell
979
-23
-2% -$7.74K 0.02% 544
2025
Q2 		$288K Sell
1,002
-103
-9% -$30.8K 0.01% 613
2025
Q1 		$341K Sell
1,105
-61
-5% -$20.9K 0.02% 535
2024
Q4 		$411K Buy
1,166
+132
+13% +$48.5K 0.02% 479
2024
Q3 		$371K Buy
1,034
+115
+13% +$38.8K 0.02% 496
2024
Q2 		$293K Sell
919
-13
-1% -$3.44K 0.02% 547
2024
Q1 		$214K Sell
932
-27
-3% -$6.09K 0.01% 618
2023
Q4 		$211K Hold
959
– – 0.02% 583
2023
Q3 		$217K Sell
959
-20
-2% -$4.61K 0.02% 555
2023
Q2 		$216K Sell
979
-26
-3% -$5.76K 0.02% 568
2023
Q1 		$225K Sell
1,005
-27
-3% -$6.66K 0.02% 559
2022
Q4 		$287K Buy
1,032
+68
+7% +$17.2K 0.03% 469
2022
Q3 		$202K Buy
+964
New +$216K 0.02% 548
2020
Q4 		– Sell
-100
Closed -$10K – 1708
2020
Q3 		$10K Hold
100
– – ﹤0.01% 1340
2020
Q2 		$12K Hold
100
– – ﹤0.01% 1306
2020
Q1 		$9K Hold
100
– – ﹤0.01% 1280
2019
Q4 		$9K Hold
100
– – ﹤0.01% 1384
2019
Q3 		$7K Hold
100
– – ﹤0.01% 1406
2019
Q2 		$7K Hold
100
– – ﹤0.01% 1416
2019
Q1 		$11K Hold
100
– – ﹤0.01% 1278
2018
Q4 		$10K Hold
100
– – ﹤0.01% 1236
2018
Q3 		$13K Hold
100
– – ﹤0.01% 1307
2018
Q2 		$11K Buy
+100
New +$11K ﹤0.01% 1348

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Flagship Harbor Advisors's UTHR Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 108 shares — an estimated $52.6K sold.

Flagship Harbor Advisors first reported a position in UTHR in Q2 2018 and held it in 24 quarters. The position peaked at $411K in Q4 2024. 853 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 108 United Therapeutics shares in Q1 2026, an estimated $52.6K.
  • Flagship Harbor Advisors first reported a position in United Therapeutics in Q2 2018 and held it in 24 quarters.
  • Flagship Harbor Advisors's United Therapeutics position peaked at $411K in Q4 2024.
  • 853 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.